NCIC Clinical Trials Group
Brain Gastro-Intestinal Gynecologic Hematologic Lung Sarcoma
Breast Genito-Urinary Head & Neck IND Melanoma Symptom Control

Current Trials

Please select a disease site then trial for information such as:
Downloadable: Protocols / Consents / Forms, Administrative Updates / Amendments, Letters / Memos, Trial Summaries, Spring Meeting Cover Page, E-mail Contacts

Planned Trials

CEC.4   /    GA.1   /    LYC.1   /    LY.16   /    ALC.3
Meeting Reports

IND Meeting Reports: 2008-2013

Spring Meeting 2013 Trial Reports

Spring Meeting 2012 Trial Reports

Spring Meeting 2011 Trial Reports

Spring Meeting 2010 Trial Reports

Spring Meeting 2009 Trial Reports

Trial Accrual: Phase III Studies

Trial Accrual: IND Studies

Safety Information

General Information
Safety Reports Required Ethics Education
Web-Based Safety Reports Monitoring Utility Frequently Asked Questions Memo Re: Changes in CRF and EDC Folder Signature Requirements
AdEERS Reporting [trials using NCI US investigational agents] GCP Training
Data Safety Monitoring Committee (DSMC) - Summary Reports Revised RECIST guideline (version 1.1)
  RECIST (version 1.0)
Utilities Guide to Completing a Participants List
Ethics Utility  Participants List Change Form
Site Training Utility Investigator Credentialing and Delegation of Duties
Permanent Trial Closure Generic Activation Forms
SI Conversion Table NCIC CTG Lost to Follow Up Policy
  NCIC CTG Withdrawal of Consent Policy
Use this to link back to CTG home only
If you have any questions, comments or suggestions, please contact our